Leadership Overview
Rho has 8 executives leading key functions including strategy, finance, operations, revenue, technology, medical affairs, and co-founding.
Dedicated to advancing drug development, Rho provides comprehensive clinical research services, driving innovation across the pharmaceutical landscape with a commitment to scientific rigor and client success.
Dedicated to advancing drug development, Rho provides comprehensive clinical research services, driving innovation across the pharmaceutical landscape with a commitment to scientific rigor and client success.
Leadership Roles at Rho
Lawrence Morentz - Chief Executive Officer
Lawrence Morentz, the Chief Executive Officer at Rho, directs the overarching corporate strategy and operational framework. Overseeing all business units, Morentz ensures alignment with the company's mission to provide comprehensive clinical research services across the drug development lifecycle. This leadership position involves guiding Rho's expansion and maintaining its status as a privately-held contract research organization. Morentz drives the company's commitment to scientific excellence and client satisfaction, fostering an environment of innovation. The Chief Executive Officer's responsibilities include strategic partnerships and long-term financial health. By focusing on market dynamics and regulatory landscapes, Lawrence Morentz positions Rho for sustained growth and impact in the biopharmaceutical sector.
Francis Wall - Chief Financial Officer
Francis Wall, the Chief Financial Officer at Rho, manages all financial operations and fiscal strategy. Overseeing budgeting, forecasting, and financial reporting, Wall ensures the fiscal integrity of the organization. This role involves strategic financial planning to support Rho's full range of clinical research services and its continued operation as a privately-held entity. The Chief Financial Officer drives financial performance, manages investment strategies, and ensures compliance with all financial regulations. Wall's oversight extends to capital allocation and risk management, safeguarding the company's assets. By optimizing financial structures, Francis Wall directly contributes to Rho's ability to fund its extensive drug development support services and maintain its market position.
Stas Johnson-Chyzhykov - Chief Operating Officer
Stas Johnson-Chyzhykov, the Chief Operating Officer at Rho, directs the execution of clinical research services and operational efficiency. Overseeing day-to-day operations, Johnson-Chyzhykov ensures the seamless delivery of services across the entire drug development process. This critical role involves optimizing resource allocation, managing project timelines, and maintaining high standards of quality for Rho's contract research organization functions. The Chief Operating Officer drives operational improvements and implements best practices to enhance service delivery. Johnson-Chyzhykov's focus is on streamlining workflows and ensuring the effective deployment of personnel and technology. By managing operational complexities, Stas Johnson-Chyzhykov supports Rho's mission to accelerate drug development for its clients.
Mary Helms - President & Co-Founder
Mary Helms, the President & Co-Founder at Rho, provides foundational leadership and strategic direction, drawing on extensive experience in clinical research. Overseeing key aspects of the company's operations and long-term vision, Helms ensures Rho continues its legacy of providing comprehensive drug development services. This role involves guiding strategic initiatives and maintaining the company's core values established since its inception. The President & Co-Founder contributes significantly to Rho's market positioning and client engagement strategies. Helms's deep understanding of the contract research landscape informs critical business decisions. By championing the company's mission, Mary Helms reinforces Rho's commitment to scientific rigor and client success in advancing pharmaceutical innovation.
Deborah Johnson - President
Deborah Johnson, the President at Rho, directs significant operational and strategic initiatives within the organization. Overseeing key business functions, Johnson ensures the effective delivery of Rho's full spectrum of clinical research services. This leadership position focuses on driving operational excellence and fostering growth across the company's service lines. The President plays a vital role in client relations and strategic partnerships, reinforcing Rho's commitment to supporting drug development. Johnson's responsibilities include enhancing service offerings and ensuring compliance with industry standards. By leading critical business units, Deborah Johnson contributes to Rho's sustained success and its reputation as a premier contract research organization.
Thomas McNulty - Chief Revenue Officer
Thomas McNulty, the Chief Revenue Officer at Rho, leads all revenue-generating activities and sales strategies. Overseeing the sales and business development teams, McNulty drives market penetration and client acquisition for Rho's comprehensive clinical research services. This executive position focuses on expanding the company's client base and maximizing revenue streams within the drug development sector. The Chief Revenue Officer develops and executes strategies to achieve ambitious sales targets and foster long-term client relationships. McNulty's responsibilities include market analysis and identifying new business opportunities. By driving revenue growth, Thomas McNulty ensures Rho's financial stability and capacity to invest in cutting-edge research support.
Biljana Djordjevic - Technology Chief of Staff
Biljana Djordjevic, the Technology Chief of Staff at Rho, aligns technology initiatives with the company's strategic objectives. Overseeing the integration and optimization of technological resources, Djordjevic ensures that Rho's infrastructure effectively supports its clinical research services. This role involves managing technology projects, driving digital transformation, and enhancing the company's technological capabilities across the drug development process. The Technology Chief of Staff collaborates with various departments to implement innovative solutions and improve operational efficiency. Djordjevic's focus is on leveraging technology to streamline research, enhance data management, and maintain a competitive edge. By driving technological advancements, Biljana Djordjevic strengthens Rho's position as a leading contract research organization.
Andrew Feigin - Chief Medical Officer
Andrew Feigin, the Chief Medical Officer at Rho, provides critical medical and scientific leadership for clinical research programs. Overseeing the medical strategy and scientific integrity of studies, Feigin ensures that Rho's services align with the highest standards of medical practice and regulatory compliance. This role involves guiding the interpretation of clinical data and advising on therapeutic areas across the drug development spectrum. The Chief Medical Officer contributes expertise in clinical trial design and execution, ensuring patient safety and data validity. Feigin's responsibilities include scientific consultation and fostering relationships with the medical community. By leading medical affairs, Andrew Feigin enhances Rho's reputation for scientific excellence and its ability to support complex research initiatives.
Explore Leadership Teams in Business Services
Fortrea is a global clinical research organization that specializes in navigating the complexities of clinical trials and research and development services. Founded in 2006, the company provides comprehensive clinical research solutions with a focus on scientific rigor and innovative problem-solving. Fortrea offers services that help transform promising medical ideas into proven therapies, supporting the entire clinical development process. With operations across North America, Europe, Asia Pacific, Africa, and South America, Fortrea serves clients in the pharmaceutical, biotechnology, and healthcare industries through its extensive network of research facilities and specialized teams.
Company Leadership SD
MM
JM
Brookings Institution operates as a nonprofit public policy research organization dedicated to generating actionable insights that address complex societal challenges. The organization conducts rigorous, in-depth research across multiple domains, translating academic inquiry into practical solutions for policymakers, business leaders, and civic stakeholders. Through its multidisciplinary approach, Brookings examines pressing issues spanning economics, governance, international affairs, and social policy, producing analysis that informs decision-making at local, national, and global scales. The institution's research methodology combines empirical investigation with expert analysis, drawing on scholars and practitioners who bring deep subject matter expertise to their work. Brookings produces comprehensive reports, policy briefs, and thought leadership that synthesize complex data into accessible recommendations. The organization's work spans both domestic policy challenges and international relations, reflecting the interconnected nature of modern governance and economic systems. Brookings maintains a commitment to nonpartisan analysis, striving to present evidence-based perspectives that transcend ideological boundaries. The institution engages with government officials, corporate executives, nonprofit leaders, and the broader public through publications, conferences, and direct consultation.
Company Leadership
AM
ST
The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.
Company Leadership
JP
Founded in 1969, Bionetics Corporation is a company that offers environmental monitoring, readiness monitoring, and instrument calibration services. They are based in Yorktown, Virginia.
Company Leadership CH
KV
CR
DT
Frequently Asked Questions Regarding Rho Top Executives and Leadership Team
